Publications

Found 2 results
Filters: Author is H. Wei  [Clear All Filters]
2012
Q. Pan, Ning, Y., Chen, L. Z., Zhang, S., Liu, Z. Z., Yang, X. X., Wei, W., Wei, H., Li, Q. G., Yue, H. N., and Wang, J. X., Association of MHC class-III gene polymorphisms with ER-positive breast cancer in Chinese Han population, vol. 11, pp. 4299-4306, 2012.
Anderson WF, Chu KC, Chatterjee N, Brawley O, et al. (2001). Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. J. Clin. Oncol. 19: 18-27. PMid:11134191   Baccar HA, Yacoubi LB, Troudi W, Hmida S, et al. (2006). HLA class II polymorphism: protective or risk factors to breast cancer in Tunisia? Pathol. Oncol. Res. 12: 79-81. http://dx.doi.org/10.1007/BF02893448   Bhutia SK, Mallick SK and Maiti TK (2010). Tumour escape mechanisms and their therapeutic implications in combination tumour therapy. Cell Biol. Int. 34: 553-563. http://dx.doi.org/10.1042/CBI20090206 PMid:20384587   Cantú de León D, Perez-Montiel D, Villavicencio V, Garcia CA, et al. (2009). High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study. BMC Cancer 9: 48. http://dx.doi.org/10.1186/1471-2407-9-48 PMid:19196481 PMCid:2653544   de Jong MM, Nolte IM, de Vries EG, Schaapveld M, et al. (2003). The HLA class III subregion is responsible for an increased breast cancer risk. Hum. Mol. Genet. 12: 2311-2319. http://dx.doi.org/10.1093/hmg/ddg245 PMid:12915440   Dunn GP, Bruce AT, Ikeda H, Old LJ, et al. (2002). Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3: 991-998. http://dx.doi.org/10.1038/ni1102-991 PMid:12407406   Dunnwald LK, Rossing MA and Li CI (2007). Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 9: R6. http://dx.doi.org/10.1186/bcr1639 PMid:17239243 PMCid:1851385   Ghaderi A, Talei A, Gharesi-Fard B, Farjadian SH, et al. (2001). HLA-DBR 1 alleles and the susceptibility of Iranian patients with breast cancer. Pathol. Oncol. Res. 7: 39-41. http://dx.doi.org/10.1007/BF03032603 PMid:11349219   Gruen JR and Weissman SM (2001). Human MHC class III and IV genes and disease associations. Front Biosci. 6: D960-D972. http://dx.doi.org/10.2741/Gruen PMid:11487469   Gun FD, Ozturk OG, Polat A and Polat G (2012). HLA class-II allele frequencies in Turkish breast cancer patients. Med. Oncol. 29: 466-471. http://dx.doi.org/10.1007/s12032-011-9873-4 PMid:21373933   Hashimoto M, Nakamura N, Obayashi H, Kimura F, et al. (1999). Genetic contribution of the BAT2 gene microsatellite polymorphism to the age-at-onset of insulin-dependent diabetes mellitus. Hum. Genet. 105: 197-199. http://dx.doi.org/10.1007/s004390051089 PMid:10987645   Iris FJ, Bougueleret L, Prieur S, Caterina D, et al. (1993). Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment. Nat. Genet. 3: 137-145. http://dx.doi.org/10.1038/ng0293-137 PMid:8499947   Jemal A, Bray F, Center MM, Ferlay J, et al. (2011). Global cancer statistics. CA Cancer J. Clin. 61: 69-90. http://dx.doi.org/10.3322/caac.20107 PMid:21296855   Lavado R, Benavides M, Villar E, Ales I, et al. (2005). The HLA-B7 allele confers susceptibility to breast cancer in Spanish women. Immunol. Lett. 101: 223-225. http://dx.doi.org/10.1016/j.imlet.2005.03.006 PMid:16188571   Linos E, Spanos D, Rosner BA, Linos K, et al. (2008). Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J. Natl. Cancer Inst. 100: 1352-1360. http://dx.doi.org/10.1093/jnci/djn305 PMid:18812552 PMCid:2556703   Mahmoodi M, Nahvi H, Mahmoudi M, Kasaian A, et al. (2012). HLA-DRB1, -DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer. Pathol. Oncol. Res. 18: 49-55. http://dx.doi.org/10.1007/s12253-011-9415-6 PMid:21720852   Mestiri S, Bouaouina N, Ahmed SB, Khedhaier A, et al. (2001). Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer 91: 672-678. http://dx.doi.org/10.1002/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J   Milner CM and Campbell RD (2001). Genetic organization of the human MHC class III region. Front Biosci. 6: D914-D926. http://dx.doi.org/10.2741/Milner PMid:11487476   Shiina T, Inoko H and Kulski JK (2004). An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64: 631-649. http://dx.doi.org/10.1111/j.1399-0039.2004.00327.x PMid:15546336   Singal DP, Li J and Zhu Y (2000). HLA class III region and susceptibility to rheumatoid arthritis. Clin. Exp. Rheumatol. 18: 485-491. PMid:10949724   Spies T, Blanck G, Bresnahan M, Sands J, et al. (1989). A new cluster of genes within the human major histocompatibility complex. Science 243: 214-217. http://dx.doi.org/10.1126/science.2911734 PMid:2911734   Xie T, Rowen L, Aguado B, Ahearn ME, et al. (2003). Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse. Genome Res. 13: 2621-2636. http://dx.doi.org/10.1101/gr.1736803 PMid:14656967 PMCid:403804   Yu CY (1998). Molecular genetics of the human MHC complement gene cluster. Exp. Clin. Immunogenet. 15: 213-230. http://dx.doi.org/10.1159/000019075 PMid:10072631   Ziegler RG, Anderson WF and Gail MH (2008). Increasing breast cancer incidence in China: the numbers add up. J. Natl. Cancer Inst. 100: 1339-1341. http://dx.doi.org/10.1093/jnci/djn330 PMid:18812546